EatingWell on MSN
The FDA just approved a new cholesterol pill—here’s what cardiologists want you to knowNot to be confused with statins, this new pill is the first of its kind.
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
The drug from Merck was OK'd for patients with artery-clogging cholesterol that persists even after taking statins.
Most adults have levels of a dangerous type of cholesterol that are above 100, but this new drug can reduce levels to around 50 ...
July 16 (Reuters) - Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator's nod, bolstering the drugmaker's efforts to diversify ...
Lipfendra, to be taken once a day, is designed to help lower cholesterol levels beyond what statins alone can achieve.
The daily medication is expected to be list-priced at $10.50 per pill. Here's what to know about Merck's new cholesterol drug Lipfendra.
Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only ...
On July 16, 2026, the FDA approved the first pill version of this same idea: Lipfendra (enlicitide), a once-daily tablet for adults with high cholesterol (LDL-C), including an inherited form called ...
The Washington Post on MSN
Should you take the powerful new cholesterol pill approved by the FDA?The drug is the first oral form of a class of powerful cholesterol-fighting drugs called PCSK9 inhibitors.
The U.S. Food and Drug Administration (FDA) has approved a new cholesterol-lowering pill that could help reduce LDL, or the so-called “bad” cholesterol. Dr. Jeffrey Berman, ...
This is read by an automated voice. Please report any issues or inconsistencies here. WASHINGTON — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results